204 related articles for article (PubMed ID: 19543317)
41. Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer.
Lee KS; Lee YS; Lee JM; Ito K; Cinghu S; Kim JH; Jang JW; Li YH; Goh YM; Chi XZ; Wee H; Lee HW; Hosoya A; Chung JH; Jang JJ; Kundu JK; Surh YJ; Kim WJ; Ito Y; Jung HS; Bae SC
Oncogene; 2010 Jun; 29(23):3349-61. PubMed ID: 20228843
[TBL] [Abstract][Full Text] [Related]
42. Overexpression of BMI1 confers clonal cells resistance to apoptosis and contributes to adverse prognosis in myelodysplastic syndrome.
Xu F; Yang R; Wu L; He Q; Zhang Z; Zhang Q; Yang Y; Guo J; Chang C; Li X
Cancer Lett; 2012 Apr; 317(1):33-40. PubMed ID: 22120066
[TBL] [Abstract][Full Text] [Related]
43. Bmi1 directly represses p21Waf1/Cip1 in Shh-induced proliferation of cerebellar granule cell progenitors.
Subkhankulova T; Zhang X; Leung C; Marino S
Mol Cell Neurosci; 2010 Oct; 45(2):151-62. PubMed ID: 20600931
[TBL] [Abstract][Full Text] [Related]
44. Bmi1 and cell of origin determinants of brain tumor phenotype.
Dirks P
Cancer Cell; 2007 Oct; 12(4):295-7. PubMed ID: 17936553
[TBL] [Abstract][Full Text] [Related]
45. Bmi1 promotes prostate tumorigenesis via inhibiting p16(INK4A) and p14(ARF) expression.
Fan C; He L; Kapoor A; Gillis A; Rybak AP; Cutz JC; Tang D
Biochim Biophys Acta; 2008 Nov; 1782(11):642-8. PubMed ID: 18817867
[TBL] [Abstract][Full Text] [Related]
46. Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice.
Oguro H; Iwama A; Morita Y; Kamijo T; van Lohuizen M; Nakauchi H
J Exp Med; 2006 Oct; 203(10):2247-53. PubMed ID: 16954369
[TBL] [Abstract][Full Text] [Related]
47. Long-term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1.
Rizo A; Dontje B; Vellenga E; de Haan G; Schuringa JJ
Blood; 2008 Mar; 111(5):2621-30. PubMed ID: 18156489
[TBL] [Abstract][Full Text] [Related]
48. Validation of Bmi1 as a therapeutic target of hepatocellular carcinoma in mice.
Qi S; Li B; Yang T; Liu Y; Cao S; He X; Zhang P; Li L; Xu C
Int J Mol Sci; 2014 Nov; 15(11):20004-21. PubMed ID: 25372945
[TBL] [Abstract][Full Text] [Related]
49. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells.
Gergely JE; Dorsey AE; Dimri GP; Dimri M
Mol Carcinog; 2018 Jul; 57(7):831-841. PubMed ID: 29528145
[TBL] [Abstract][Full Text] [Related]
50. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
[TBL] [Abstract][Full Text] [Related]
51. GFAP-Cre-mediated transgenic activation of Bmi1 results in pituitary tumors.
Westerman BA; Blom M; Tanger E; van der Valk M; Song JY; van Santen M; Gadiot J; Cornelissen-Steijger P; Zevenhoven J; Prosser HM; Uren A; Aronica E; van Lohuizen M
PLoS One; 2012; 7(5):e35943. PubMed ID: 22574128
[TBL] [Abstract][Full Text] [Related]
52. Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus.
Tzatsos A; Pfau R; Kampranis SC; Tsichlis PN
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2641-6. PubMed ID: 19202064
[TBL] [Abstract][Full Text] [Related]
53.
Umbreen S; Banday MM; Jamroze A; Mansini AP; Ganaie AA; Ferrari MG; Maqbool R; Beigh FH; Murugan P; Morrissey C; Corey E; Konety BR; Saleem M
Mol Cancer Ther; 2019 Nov; 18(11):2111-2123. PubMed ID: 31467179
[TBL] [Abstract][Full Text] [Related]
54. Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence.
Agherbi H; Gaussmann-Wenger A; Verthuy C; Chasson L; Serrano M; Djabali M
PLoS One; 2009 May; 4(5):e5622. PubMed ID: 19462008
[TBL] [Abstract][Full Text] [Related]
55. Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation.
Lessard J; Schumacher A; Thorsteinsdottir U; van Lohuizen M; Magnuson T; Sauvageau G
Genes Dev; 1999 Oct; 13(20):2691-703. PubMed ID: 10541555
[TBL] [Abstract][Full Text] [Related]
56. The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity.
Chatoo W; Abdouh M; David J; Champagne MP; Ferreira J; Rodier F; Bernier G
J Neurosci; 2009 Jan; 29(2):529-42. PubMed ID: 19144853
[TBL] [Abstract][Full Text] [Related]
57. Direct activation of Bmi1 by Twist1: implications in cancer stemness, epithelial-mesenchymal transition, and clinical significance.
Wu KJ
Chang Gung Med J; 2011; 34(3):229-38. PubMed ID: 21733352
[TBL] [Abstract][Full Text] [Related]
58. [Regulation of lineage specification of hematopoietic stem cells by polycomb group gene Bmi1].
Oguro H
Rinsho Ketsueki; 2011 Feb; 52(2):51-7. PubMed ID: 21403423
[No Abstract] [Full Text] [Related]
59. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.
Jacobs JJ; Keblusek P; Robanus-Maandag E; Kristel P; Lingbeek M; Nederlof PM; van Welsem T; van de Vijver MJ; Koh EY; Daley GQ; van Lohuizen M
Nat Genet; 2000 Nov; 26(3):291-9. PubMed ID: 11062467
[TBL] [Abstract][Full Text] [Related]
60. Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.
Fang X; Cai Y; Liu J; Wang Z; Wu Q; Zhang Z; Yang CJ; Yuan L; Ouyang G
Oncogene; 2011 Nov; 30(47):4707-20. PubMed ID: 21602879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
